High Wilms' tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1231-1236

  Qi, Xiao Wei ^a   Zhang, Fan ^a   Yang, Xin Hua ^a   Fan, Lin Jun ^a   Zhang, Yi ^a   Liang, Yan ^a   Ren, Lin ^a   Zhong, Ling ^a   Chen, Qing Qiu ^a   Zhang, Kong Yong ^a   Zang, Wei Dong ^b   Wang, Li Shan ^b   Zhang, Ying ^c   Jiang, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c CITY COLLEGE OF SAN FRANCISCO   (United States)

Author keywords

Breast cancer; Molecular subtype; Prognosis; Wilms' tumor 1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; MESSENGER RNA; WT1 PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BASAL LIKE BREAST CANCER; BIOINFORMATICS; BREAST CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE FUNCTION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR GENE; TUMOR VOLUME; WILMS TUMOR 1 GENE;

BREAST NEOPLASMS; DATABASES, GENETIC; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, WILMS TUMOR; HUMANS; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; RNA, MESSENGER;

EID: 84866458962     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1906     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global Cancer Statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
3. Gumireddy K, Li A, Gimotty PA, Klein-Szanto AJ, Showe LC, Katsaros D, et al: KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol 11: 1297-1304, 2009.
4. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, et al: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61: 1257-1269, 1990.
5. Little M and Wells C: A clinical overview of WT1 gene mutations. Hum Mutat 9: 209-225, 1997. (Pubitemid 27138814)
6. Loeb DM and Sukumar S: The role of WT1 in oncogenesis: tumor suppressor or oncogene? Int J Hematol 76: 117-126, 2002. (Pubitemid 43020324)
7. Hohenstein P and Hastie ND: The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 15: R196-R201, 2006. (Pubitemid 44446794)
8. Yang L, Han Y, Suarez Saiz F and Minden MD: A tumor suppressor and oncogene: the WT1 story. Leukemia 21: 868-876, 2007. (Pubitemid 46672061)
9. Sugiyama H: WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol 40: 377-387, 2010.
10. Huff V: Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 11: 111-121, 2011.
11. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al: Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90: 194-204, 1999. (Pubitemid 29112320)
12. Silberstein GB, Van Horn K, Strickland P, Roberts CT Jr and Daniel CW: Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA 94: 8132-8137, 1997. (Pubitemid 27343789)
13. Zhang TF, Yu SQ, Guan LS and Wang ZY: Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin. Anticancer Res 23: 3575-3584, 2003.
14. Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, et al: The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. J Mol Endocrinol 35: 135-144, 2005. (Pubitemid 41167631)
15. Wang L and Wang ZY: The Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells. Anticancer Res 28: 2155-2160, 2008.
16. Oji Y, Miyoshi Y, Kiyotoh E, Koga S, Nakano Y, Ando A, et al: Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer. Jpn J Clin Oncol 34: 74-77, 2004. (Pubitemid 43115322)
17. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, et al: Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61: 921-925, 2001. (Pubitemid 32174404)
18. Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, et al: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8: 1167-1171, 2002. (Pubitemid 34517654)
19. Zapata-Benavides P, Tuna M, Lopez-Berestein G and Tari AM: Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun 295: 784-790, 2002.
20. Tuna M, Chavez-Reyes A and Tari AM: HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene 24: 1648-1652, 2005. (Pubitemid 40396095)
21. Caldon CE, Lee CS, Sutherland RL and Musgrove EA: Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene 27: 126-138, 2008.
22. Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J and Minden MD: Wilms' tumor 1 suppressor gene mediates anti-estrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells. Mol Cancer Res 6: 1347-1355, 2008.
23. Camci C, Kalender ME, Paydaş S, Sevinç A, Zorludemir S and Suner A: Prognostic significance of Wilms Tumor 1 (WT1) protein expression in breast cancer. Gaziantep Med J 17: 67-72, 2011.
24. Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E, et al: A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat 126: 407-420, 2011.
25. Finetti P, Cervera N, Charafe-Jauffret E, Chabannon C, Charpin C, Chaffanet M, et al: Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. Cancer Res 68: 767-776, 2008. (Pubitemid 351206753)
26. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003.
27. Nie H, Neerincx PB, van der Poel J, Ferrari F, Bicciato S, Leunissen JA, et al: Microarray data mining using Bioconductor packages. BMC Proc 3: S9, 2009.
28. Crawford JR and Garthwaite PH: Single-case research in neuropsychology: A comparison of five forms of t-test for comparing a case to controls. Cortex: Jul 23, 2011 (Epub ahead of print).
29. Diboun I, Wernisch L, Orengo CA and Koltzenburg M: Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7: 252, 2006.
30. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
31. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874, 2001. (Pubitemid 32878711)
32. Stoll R, Lee BM, Debler EW, Laity JH, Wilson IA, Dyson HJ, et al: Structure of the Wilms tumor suppressor protein zinc finger domain bound to DNA. J Mol Biol 372: 1227-1245, 2007. (Pubitemid 47374717)
33. Martínez-Estrada OM, Lettice LA, Essafi A, Guadix JA, Slight J, Velecela V, et al: Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet 42: 89-93, 2010.
34. Sera T, Hiasa Y, Mashiba T, Tokumoto Y, Hirooka M, Konishi I, et al: Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis. Eur J Cancer 44: 600-608, 2008.
35. Perugorria MJ, Castillo J, Latasa MU, Goni S, Segura V, Sangro B, et al: Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Cancer Res 69: 1358-1367, 2009.
36. Tatsumi N, Oji Y, Tsuji N, Tsuda A, Higashio M, Aoyagi S, et al: Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. Int J Oncol 32: 701-711, 2008. (Pubitemid 351330477)
37. McCarty G, Awad O and Loeb DM: WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia. J Biol Chem 286: 43634-43643, 2011.
38. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, et al: Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 97: 259-270, 2006.